Literature DB >> 32568182

MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.

Yong-Mei Zhou1,2,3,1, Yi-Lin Yao2,3,1, Wei Liu3,4, Xue-Min Shen2,3, Lin-Jun Shi2,3, Lan Wu2,3.   

Abstract

BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most common malignant neoplasm of the mouth. Some studies have found that multiple microRNAs (miRs) participate in OSCC physiological and pathological processes.
METHODS: We explored the mechanism of action of miR-134 in OSCC involving the PI3K-Akt signaling pathway. Different bioinformatics methods were used to analyze the potential genes and their related miRs in OSCC. Tumor stem cells were separated from OSCCs through magnetic cell sorting. Regulatory pattern between miR-134 and LAMC2 in OSCC was evaluated by ectopic expression, knockdown and reporter assay experiments. The expression of miR-134, LAMC2, genes in PI3K-Akt signaling pathway, and apoptosis-related genes was detected. Cell proliferation was assessed by MTT assay, cell invasion by scratch test, cell migration by Transwell assay, cell cycle and apoptosis by flow cytometry, and cell growth and migration by xenograft tumor in nude mice. LAMC2 was predicted as the crucial factor related to OSCC using different chip data, and miR-134 was predicted to specifically bind LAMC2 in all five databases.
RESULTS: Overexpressed miR-134 or silenced LAMC2 was observed to inhibit cell proliferation, migration, invasion of OSCC cells, growth of subcutaneous xenograft in nude mice, as well as promote OSCC cell apoptosis. LAMC2, a target gene of miR-134, decreased following miR-134 promotion, while the PI3K-Akt signaling pathway was inactivated following LAMC2 knockdown. Furthermore, we also observed that the effect of overexpressed miR-134 was enhanced when LAMC2 was knocked down.
CONCLUSIONS: Taken together, these findings suggest that miR-134-mediated direct downregulation of LAMC2 inhibits migration and invasion of tumor stem cells in OSCC by suppressing the PI3K-Akt signaling pathway.

Entities:  

Keywords:  LAMC2; MicroRNA-134; PI3K-Akt signaling pathway; cell invasion; cell migration; oral squamous cell carcinoma

Mesh:

Substances:

Year:  2020        PMID: 32568182     DOI: 10.3233/CBM-191362

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  9 in total

1.  LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis.

Authors:  Fan Ma; Ziran Wang; Yawen Qiang; Liangfei Xu; Pengsheng Ding; Yangyan Wang; Xiaoling Ma
Journal:  Onco Targets Ther       Date:  2020-10-12       Impact factor: 4.147

2.  Long non-coding RNA BBOX1-antisense RNA 1 enhances cell proliferation and migration and suppresses apoptosis in oral squamous cell carcinoma via the miR-3940-3p/laminin subunit gamma 2 axis.

Authors:  Chunguang Zhao; Wei Shi; Min Chen
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  Activation of the miR-371/372/373 miRNA Cluster Enhances Oncogenicity and Drug Resistance in Oral Carcinoma Cells.

Authors:  Shu-Chun Lin; Hsiao-Li Wu; Li-Yin Yeh; Cheng-Chieh Yang; Shou-Yen Kao; Kuo-Wei Chang
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

4.  Long non-coding RNA CASC9 promotes tumor progression in oral squamous cell carcinoma by regulating microRNA-545-3p/laminin subunit gamma 2.

Authors:  Baoshan Ning; Songya Guo; Yine Mei
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 5.  Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers.

Authors:  Soudeh Ghafouri-Fard; Ali Noie Alamdari; Yashar Noee Alamdari; Atefe Abak; Bashdar Mahmud Hussen; Mohammad Taheri; Elena Jamali
Journal:  Cancer Cell Int       Date:  2022-08-13       Impact factor: 6.429

Review 6.  Invasion-Associated Reorganization of Laminin 332 in Oral Squamous Cell Carcinomas: The Role of the Laminin γ2 Chain in Tumor Biology, Diagnosis, and Therapy.

Authors:  Alexander Berndt; Nikolaus Gaßler; Marcus Franz
Journal:  Cancers (Basel)       Date:  2022-10-07       Impact factor: 6.575

7.  COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing's Sarcoma.

Authors:  Min Tang; Peiqing Liu; Xiaoke Wu; Jie Gong; Jiacheng Weng; Guangyu Gao; Yulong Liu; Lei Gan
Journal:  Biomed Res Int       Date:  2021-12-22       Impact factor: 3.411

8.  RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocarcinoma tissues.

Authors:  Guihua Jin; Qingqing Ruan; Fugen Shangguan; Linhua Lan
Journal:  Aging (Albany NY)       Date:  2021-10-04       Impact factor: 5.682

9.  Transcriptomic Biomarker Signatures for Discrimination of Oral Cancer Surgical Margins.

Authors:  Simon A Fox; Michael Vacher; Camile S Farah
Journal:  Biomolecules       Date:  2022-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.